2000
Obstacles to Promotion? Values of Women Faculty about Career Success and Recognition
Buckley L, Sanders K, Shih M, Kallar S, Hampton C. Obstacles to Promotion? Values of Women Faculty about Career Success and Recognition. Academic Medicine 2000, 75: 283-288. PMID: 10724319, DOI: 10.1097/00001888-200003000-00021.Peer-Reviewed Original Research
1999
Prevention of corticosteroid‐induced osteoporosis: Results of a patient survey
Buckley L, Marquez M, Feezor R, Ruffin D, Benson L. Prevention of corticosteroid‐induced osteoporosis: Results of a patient survey. Arthritis & Rheumatism 1999, 42: 1736-1739. PMID: 10446875, DOI: 10.1002/1529-0131(199908)42:8<1736::aid-anr24>3.0.co;2-e.Peer-Reviewed Original ResearchConceptsBone density testingCorticosteroid-induced osteoporosisCorticosteroid treatmentPreventive treatmentLong-term oral corticosteroid treatmentLong-term corticosteroid usersLong-term corticosteroid treatmentDensity testingMean prednisone doseOral corticosteroid treatmentBone density testHormone replacement therapyPrimary care physiciansStandard of careCorticosteroid usersPMP womenPrednisone dosePostmenopausal womenBisphosphonate treatmentCare physiciansOsteoporosis preventionBone lossReplacement therapyCalcium supplementsPatient survey
1998
Perceptions of Pharmacists about Adverse Effects of Corticosteroid Therapy: Focus on Osteoporosis
Hudson J, Small R, Buckley L. Perceptions of Pharmacists about Adverse Effects of Corticosteroid Therapy: Focus on Osteoporosis. Journal Of The American Pharmacists Association 1998, 38: 710-716. PMID: 9861789, DOI: 10.1016/s1086-5802(16)30392-8.Peer-Reviewed Original ResearchConceptsCorticosteroid therapyPerceptions of pharmacistsCorticosteroid usePostmenopausal womenPremenopausal womenAdverse effectsPatient counselingHigh-dose corticosteroid useWeight gainCorticosteroid-induced osteoporosisHigh-dose corticosteroidsHigh-dose therapyDrug-induced complicationsPrevention of osteoporosisPrednisone useBone densityOsteoporosisHospital pharmacistsMailed surveyTherapyMood changesPharmacistsWomenRespondents' knowledgeCorticosteroidsVariations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
Buckley L, Marquez M, Hudson J, Downs R, Vacek P, Small R, Poses R. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty. The Journal Of Rheumatology 1998, 25: 2195-202. PMID: 9818664.Peer-Reviewed Original ResearchConceptsEstrogen replacement therapyCorticosteroid treatmentPhysician judgmentCorticosteroid usePhysician specialtySide effectsPostmenopausal patientsVitamin DBone lossReplacement therapyCorticosteroid-induced osteoporosisImportance of osteoporosisVitamin D supplementationMajority of patientsRisk of osteoporosisPrimary care physiciansSignificant side effectsHypothetical clinical scenariosImportance of corticosteroidsEfficacy of treatmentD supplementationPostmenopausal womenPremenopausal womenPhysician assessmentCare physicians
1997
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
Tuttleman M, Pillemer S, Tilley B, Fowler S, Buckley L, Alarcón G, Trentham D, Neuner R, Clegg D, Leisen J, Heyse S. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. The Journal Of Rheumatology 1997, 24: 1910-5. PMID: 9330931.Peer-Reviewed Original ResearchConceptsPatient global assessmentSF-36Rheumatoid arthritisM-HAQOutcome measuresClinical trialsGlobal assessmentShort Form Health SurveyFunctional health status measuresJoint swelling scoreRA clinical trialsRA outcome measuresHealth Assessment QuestionnaireHealth status instrumentsSF-36 scalesRheumatoid arthritis trialsHealth status measuresMultitrait scaling analysisCross-sectional assessmentCross-sectional analysisMIRA trialStudy patientsRA populationScore correlationsPain itemsImportance of guidelines on glucocorticoid‐induced osteoporosis: Comment on the American college of rheumatology recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
Buckley L. Importance of guidelines on glucocorticoid‐induced osteoporosis: Comment on the American college of rheumatology recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis. Arthritis & Rheumatism 1997, 40: 1547-1547. PMID: 9259442, DOI: 10.1002/art.1780400829.Peer-Reviewed Original ResearchEffects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
Buckley L, Leib E, Cartularo K, Vacek P, Cooper S. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. The Journal Of Rheumatology 1997, 24: 1489-94. PMID: 9263140.Peer-Reviewed Original ResearchConceptsBone mineral densityLow-dose methotrexateRheumatoid arthritisLumbar spineFemoral neckDose methotrexateMineral densityBMD of patientsFemoral neck bone mineral densityNeck bone mineral densitySpine bone mineral densityMeasurement of BMDAntirheumatic drug useVitamin D3 supplementationYears of followupGreater bone lossDMARD useD3 supplementationFollowup visitMTX useBone lossPrednisoneSimilar dosePatientsMethotrexateRadiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
Bluhm G, Sharp J, Tilley B, Alarcon G, Cooper S, Pillemer S, Clegg D, Heyse S, Trentham D, Neuner R, Kaplan D, Leisen J, Buckley L, Duncan H, Tuttleman M, Li S, Fowler S. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. The Journal Of Rheumatology 1997, 24: 1295-302. PMID: 9228128.Peer-Reviewed Original ResearchConceptsJoint space narrowingRheumatoid arthritis trialsDisease progressionArthritis trialsSpace narrowingPercentage of patientsSignificant differencesReported clinical resultsErosive jointsOral minocyclinePlacebo groupErosive diseaseFinal visitRadiographic progressionPlacebo treatmentTreat analysisRadiographic resultsFuture trialsClinical centersClinical resultsPosteroanterior filmsRadiographic changesTreatment benefitProgression rateWeek trialMultiple congenital anomalies associated with weekly low‐dose methotrexate treatment of the mother
Buckley L, Bullaboy C, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low‐dose methotrexate treatment of the mother. Arthritis & Rheumatism 1997, 40: 971-973. PMID: 9153561, DOI: 10.1002/art.1780400527.Peer-Reviewed Original ResearchConceptsWeekly low-dose methotrexateLow-dose methotrexateMultiple congenital anomaliesCongenital anomaliesLow-dose MTX treatmentLow-dose methotrexate treatmentJuvenile rheumatoid arthritisFirst case reportGroup of abnormalitiesMultiple congenital abnormalitiesMethotrexate treatmentMTX treatmentRheumatoid arthritisFirst trimesterCase reportMaternal ingestionSpontaneous abortionCongenital abnormalitiesMethotrexateDosage levelsAbnormalitiesMothersAbortionTreatmentReport
1996
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Buckley L, Leib E, Cartularo K, Vacek P, Cooper S. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Annals Of Internal Medicine 1996, 125: 961-8. PMID: 8967706, DOI: 10.7326/0003-4819-125-12-199612150-00004.Peer-Reviewed Original ResearchConceptsBone mineral densityLow-dose corticosteroidsPlacebo-controlled trialVitamin D3 supplementationMineral densityRheumatoid arthritisVitamin D3Prednisone therapyLumbar spineD3 supplementationBone lossOutpatient care facilitiesLong-term useCorticosteroid useVertebral fracturesWard's triangleAutoimmune diseasesFemoral neckCorticosteroidsHigh riskSupplemental calciumRational therapyPatientsArthritisTherapyPrevalence of Pulmonary Hypertension in Limited and Diffuse Scleroderma
Battle R, Davitt M, Cooper S, Buckley L, Leib E, Beglin P, Tischler M. Prevalence of Pulmonary Hypertension in Limited and Diffuse Scleroderma. CHEST Journal 1996, 110: 1515-1519. PMID: 8989070, DOI: 10.1378/chest.110.6.1515.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBlood PressureCross-Sectional StudiesEchocardiography, DopplerElectrocardiographyFemaleHumansHypertension, PulmonaryMaleMiddle AgedProspective StudiesPulmonary ArteryPulmonary Diffusing CapacityPulmonary VentilationScleroderma, SystemicTricuspid Valve InsufficiencyConceptsPulmonary artery systolic pressurePulmonary hypertensionDiffuse sclerodermaTricuspid regurgitationSignificant end-organ damageProspective cross-sectional studyTranstricuspid pressure gradientUndiagnosed pulmonary hypertensionEnd-organ damageRight atrial pressureSuccessful treatment strategyCross-sectional studyAtrial pressureMost patientsConsecutive patientsSystolic pressureDoppler echocardiogramOutpatient clinicRespiratory indexClinical signsTreatment strategiesHypertensionPatientsNoninvasive assessmentScleroderma
1995
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Tilley B, Alarcón G, Heyse S, Trentham D, Neuner R, Kaplan D, Clegg D, Leisen J, Buckley L, Cooper S, Duncan H, Pillemer S, Tuttleman M, Fowler S. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Annals Of Internal Medicine 1995, 122: 81-9. PMID: 7993000, DOI: 10.7326/0003-4819-122-2-199501150-00001.Peer-Reviewed Original ResearchConceptsIgM rheumatoid factor levelsErythrocyte sedimentation rateRheumatoid factor levelsRheumatoid arthritisMinocycline groupGlobal assessmentPlacebo groupMore patientsPlatelet countModified Health Assessment QuestionnaireFactor levelsEfficacy of minocyclineEvaluator's global assessmentWeek 48 visitActive rheumatoid arthritisHealth Assessment QuestionnairePatient global assessmentPlacebo-controlled trialModerate rheumatoid arthritisDisease-modifying drugsMechanism of actionJoint tendernessMorning stiffnessStudy medicationDisease activity
1992
Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis
Buckley L, Ades P. Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis. Arthritis & Rheumatism 1992, 35: 812-814. PMID: 1622420, DOI: 10.1002/art.1780350716.Peer-Reviewed Original Research
1990
Educational and psychosocial needs of patients with chronic disease: A survey of preferences of patients with rheumatoid arthritis
Buckley L, Vacek P, Cooper S. Educational and psychosocial needs of patients with chronic disease: A survey of preferences of patients with rheumatoid arthritis. Arthritis & Rheumatism 1990, 3: 5-10. PMID: 2285739, DOI: 10.1002/art.1790030103.Peer-Reviewed Original Research